Gene Editing Provides Clues to Why Cancer Immunotherapy Often Fails
JAMA
.
2017 Nov 7;318(17):1641-1642.
doi: 10.1001/jama.2017.15507.
Author
Tracy Hampton
PMID:
29114810
DOI:
10.1001/jama.2017.15507
No abstract available
MeSH terms
CRISPR-Cas Systems
Gene Editing*
Humans
Immunotherapy*
Neoplasms / genetics*
Neoplasms / therapy
Treatment Failure